Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Genetic Tech Spn ADR (GENE)

Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,387
  • Shares Outstanding, K 3,847
  • Annual Sales, $ 5,850 K
  • Annual Income, $ -7,910 K
  • 60-Month Beta 1.14
  • Price/Sales 2.08
  • Price/Cash Flow N/A
  • Price/Book 3.89
Trade GENE with:

Options Overview Details

View History
  • Implied Volatility 116.14% ( -17.70%)
  • Historical Volatility 95.10%
  • IV Percentile 7%
  • IV Rank 5.40%
  • IV High 1,207.52% on 12/07/23
  • IV Low 53.84% on 03/15/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 11
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 109
  • Open Int (30-Day) 90

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.13 +4.69%
on 04/19/24
3.59 -37.89%
on 04/12/24
-0.47 (-17.41%)
since 03/19/24
3-Month
1.80 +23.88%
on 02/26/24
3.59 -37.89%
on 04/12/24
+0.37 (+19.89%)
since 01/19/24
52-Week
1.80 +23.88%
on 02/26/24
5.90 -62.21%
on 05/23/23
-3.42 (-60.53%)
since 04/19/23

Most Recent Stories

More News
Gene achieves key milestones and growth

MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
GeneType Risk Assessment Test onboarding in 16 clinics

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Acquisition of global direct to consumer ecommerce business

MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Genetic Technologies Reports Q2 FY22 Cash Flow Results

Q2 momentum sets the stage for a strong FY22...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Genetic Technologies Reports Q1 FY22 Results

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter ...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)
Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report®

MELBOURNE, Australia, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness...

GTG.AX : 0.140 (-20.00%)
GENE : 2.23 (-8.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across...

See More

Key Turning Points

3rd Resistance Point 3.89
2nd Resistance Point 3.55
1st Resistance Point 2.99
Last Price 2.23
1st Support Level 2.09
2nd Support Level 1.75
3rd Support Level 1.19

See More

52-Week High 5.90
Fibonacci 61.8% 4.33
Fibonacci 50% 3.85
Fibonacci 38.2% 3.37
Last Price 2.23
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar